It works whether you lose weight or not.

If someone asked about your heart health, you could probably list off your cholesterol numbers or even your latest A1C ...

Candidate profiles include HCC, liver metastases, and hepatic adenomas, including multifocal disease and stage IV patients who might otherwise be excluded from liver-directed interventions. Outpatient ...

Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available ...

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists ...

Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...

Approximately a third of the adult population worldwide has MASLD, the presence of steatosis (the accumulation of fat) in the ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Scientists have identified a particular protein in the body that may influence the progression of alcohol-associated liver ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and scarring. Signals from the gut make the situation worse by encouraging immune ...